8 citations,
September 2018 in “Anais Brasileiros De Dermatologia” Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.
November 2022 in “Skin appendage disorders” 31 citations,
November 2000 in “Clinical and Experimental Dermatology” WAA-QOL measures impact of hair loss on women's well-being.
8 citations,
July 2021 in “Patient Preference and Adherence” Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.
September 2024 in “Journal of the American Academy of Dermatology” Hair loss significantly affects the quality of life for Muslim American women, especially those not wearing hijab.
May 2011 in “Value in Health” CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.
May 2011 in “Value in Health” No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.
October 2019 in “International journal of clinical & experimental dermatology” Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.
14 citations,
August 2010 in “The Open Dermatology Journal” Australian women with female pattern hair loss have a poorer quality of life, and starting treatment doesn't immediately improve it.
July 2024 in “Journal of Cosmetic and Laser Therapy” Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.
7 citations,
March 2019 in “Medicine” Combining light therapy and microneedling shows promise for treating female hair loss.
91 citations,
July 2015 in “Anais Brasileiros De Dermatologia” Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.
53 citations,
August 2019 in “Journal of The American Academy of Dermatology” Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.
35 citations,
May 2012 in “Cochrane Database of Systematic Reviews” Minoxidil effectively treats female pattern hair loss.
21 citations,
May 2016 in “The Cochrane library” Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.
14 citations,
June 2021 in “British journal of dermatology/British journal of dermatology, Supplement” Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.
14 citations,
September 2020 in “Dermatologic Therapy” Oral minoxidil improves hair density in women with androgenetic alopecia, with mild side effects.
1 citations,
April 2009 in “Cochrane Database of Systematic Reviews” Review finds no permanent solution for female hair loss.
1 citations,
January 2009 in “Cochrane Database of Systematic Reviews” Review determines effective, safe treatments for female hair loss.
April 2003 in “Experimental Dermatology” The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.
3 citations,
August 2022 in “Journal of The American Academy of Dermatology” A 24-week randomized double-blind clinical trial evaluated the efficacy and safety of low-dose oral minoxidil (LDOM) at 0.25 mg/day versus 1 mg/day for treating female pattern hair loss (FPHL) in 30 women. The study found that the 1 mg/day dose significantly increased hair count (P < .001) compared to the 0.25 mg/day dose, which did not show significant improvement (P = .20). Both doses improved hair-shedding scores and quality of life, but no significant differences were observed between the groups in these measures. Mild facial hypertrichosis was noted in two patients on the 1 mg/day dose. The study concluded that LDOM 1 mg/day is effective and well-tolerated for FPHL, with superior efficacy to the 0.25 mg/day dose. Limitations included the small sample size and lack of a placebo group.
2 citations,
August 2010 in “The Open Dermatology Journal” March 2024 in “Healthcare” Stem cell treatment improved life quality and sexual function in women with hair loss.
16 citations,
January 2011 in “Indian Journal of Dermatology” Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.
2 citations,
July 2022 in “Frontiers in Medicine” Women with female pattern hair loss tend to have lower self-esteem and body image concerns, but higher self-esteem is linked to more self-compassion.
March 2023 in “Anais Brasileiros De Dermatologia” The document reviews various treatments for female pattern hair loss (FPHL), highlighting the efficacy and safety of different therapeutic options. Topical minoxidil is the most supported treatment but is ineffective for about 40% of patients. Oral minoxidil shows promise but has potential side effects. Antiandrogens like spironolactone and bicalutamide are effective in certain cases, with cyproterone being more effective in hyperandrogenism. Emerging treatments like microneedling, platelet-rich plasma (PRP) therapy, and low-level laser therapy (LLLT) show potential but require more research. The review emphasizes the need for personalized treatment plans and further randomized clinical trials to improve FPHL management.
15 citations,
January 2018 in “Acta dermato-venereologica” Skin treatment can lower life quality for patients with skin conditions.
30 citations,
December 1999 in “International Journal of Dermatology” Finasteride increases hair count in middle-aged and elderly men without causing sexual dysfunction.
30 citations,
December 1999 in “International Journal of Dermatology” Oral ivermectin effectively cured scabies with minimal side effects, and finasteride promoted hair growth in men with hair loss.